Monopar Therapeutics Inc.
USD113.57
+7.67 (+7.24%)
CEO
Chandler D. Robinson
IPO Date
2019-12-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$105.89
Prev. Close
$105.90
Day Low
$105.89
Day High
$113.94
52W Low
$29.18
52W High
$115.00
Market Cap
$0.76B
Volume
0.25M
| 507 |
| $92.59 |
| 2 Jul 2026 | Vu Quan Anh | Chief Financial Officer | M-Exempt | Disposed | 1,228 | $0.00 |
| 2 Jul 2026 | Robinson Chandler | director, officer: Chief Executive Officer | M-Exempt | Acquired | 12,873 | $0.00 |
| 2 Jul 2026 | Robinson Chandler | director, officer: Chief Executive Officer | F-InKind | Disposed | 4,084 | $92.59 |
| 2 Jul 2026 | Robinson Chandler | director, officer: Chief Executive Officer | M-Exempt | Disposed | 12,873 | $0.00 |
| 2 Jul 2026 | Cittadine Andrew | Chief Operating Officer | M-Exempt | Acquired | 5,254 | $0.00 |
| 2 Jul 2026 | Cittadine Andrew | Chief Operating Officer | F-InKind | Disposed | 2,309 | $92.59 |
| 2 Jul 2026 | Cittadine Andrew | Chief Operating Officer | M-Exempt | Disposed | 5,254 | $0.00 |
| 30 Jun 2026 | Sweeny Nicole | director | A-Award | Acquired | 1,284 | $87.68 |